Probing the interaction of two chemotherapeutic drugs of oxali-palladium and 5-fluorouracil simultaneously with milk carrier protein of β-lactoglobulin

International Journal of Biological Macromolecules

Volumn 112, Issue , 2018, Pages 422-432

  Leilabadi Asl, Amineh ^a   Divsalar, Adeleh ^b   Saboury, Ali Akbar ^c   Parivar, Kazem ^a  

^a ISLAMIC AZAD UNIVERSITY   (Iran)

^b KHARAZMI UNIVERSITY   (Iran)

^c UNIVERSITY OF TEHRAN   (Iran)

Author keywords

5 Fluorouracil; Chemotherapeutic drugs; Oxali palladium; Lactoglobulin

Indexed keywords

ANTINEOPLASTIC AGENT; BETA LACTOGLOBULIN; FLUOROURACIL; OXALI PALLADIUM; UNCLASSIFIED DRUG; CARRIER PROTEIN; LACTOGLOBULIN; MILK PROTEIN; PALLADIUM; PROTEIN BINDING;

ALPHA HELIX; ARTICLE; BETA SHEET; BINDING SITE; CANCER CHEMOTHERAPY; CIRCULAR DICHROISM; DRUG EFFECT; FLUORESCENCE; HYDROGEN BOND; INCUBATION TEMPERATURE; MOLECULAR DOCKING; PHOTOCHEMICAL QUENCHING; PROTEIN BINDING; PROTEIN INTERACTION; PROTEIN STRUCTURE; THERMODYNAMICS; TRANSITION TEMPERATURE; CHEMISTRY; HUMAN; NEOPLASM;

ANTINEOPLASTIC AGENTS; BINDING SITES; CARRIER PROTEINS; CIRCULAR DICHROISM; FLUOROURACIL; HUMANS; LACTOGLOBULINS; MILK PROTEINS; MOLECULAR DOCKING SIMULATION; NEOPLASMS; PALLADIUM; PROTEIN BINDING; THERMODYNAMICS;

EID: 85041691513     PISSN: 01418130     EISSN: 18790003     Source Type: Journal    
DOI: 10.1016/j.ijbiomac.2018.01.067     Document Type: Article

References (51)

1. Ghalandari, B., Divsalar, A., Eslami-Moghadam, M., Saboury, A.A., Haertlé, T., Amanlou, M., et al. Probing of the interaction between β-lactoglobulin and the anticancer drug oxaliplatin. Appl. Biochem. Biotechnol. 175 (2015), 974–987.
2. Sakurai, K., Konuma, T., Yagi, M., Goto, Y., Structural dynamics and folding of β-lactoglobulin probed by heteronuclear NMR. Biochim. Biophys. Acta Gen. Subj. 1790 (2009), 527–537.
3. Essemine, J., Hasni, I., Carpentier, R., Thomas, T., Tajmir-Riahi, H., Binding of biogenic and synthetic polyamines to β-lactoglobulin. Int. J. Biol. Macromol. 49 (2011), 201–209.
4. Ghalandari, B., Divsalar, A., Saboury, A.A., Parivar, K., β-Lactoglobulin nanoparticle as a chemotherapy agent carrier for oral drug delivery system. J. Iran. Chem. Soc. 12 (2015), 613–619.
5. Liang, L., Subirade, M., Study of the acid and thermal stability of β-lactoglobulin–ligand complexes using fluorescence quenching. Food Chem. 132 (2012), 2023–2029.
6. Ghalandari, B., Divsalar, A., Saboury, A.A., Parivar, K., The new insight into oral drug delivery system based on metal drugs in colon cancer therapy through β-lactoglobulin/oxali-palladium nanocapsules. J. Photochem. Photobiol. B Biol. 140 (2014), 255–265.
7. Sawyer, L., Kontopidis, G., The core lipocalin, bovine β-lactoglobulin. Biochim. Biophys. Acta Protein Struct. Mol. Enzymol. 1482 (2000), 136–148.
8. Liang, L., Tremblay-Hébert, V., Subirade, M., Characterisation of the β-lactoglobulin/α-tocopherol complex and its impact on α-tocopherol stability. Food Chem. 126 (2011), 821–826.
9. Papiz, M., Sawyer, L., Eliopoulos, E., North, A., Findlay, J., Sivaprasadarao, R., et al. The structure of b-lactoglobulin and its similarity to plasma retinol-binding protein. Nature 324 (1986), 383–385.
10. Longley, D.B., Harkin, D.P., Johnston, P.G., 5-Fluorouracil: mechanisms of action and clinical strategies. Nat. Rev. Cancer 3 (2003), 330–338.
11. Ishtikhar, M., Khan, S., Badr, G., Mohamed, A.O., Khan, R.H., Interaction of the 5-fluorouracil analog 5-fluoro-2′-deoxyuridine with ‘N’ and ‘B’ isoforms of human serum albumin: a spectroscopic and calorimetric study. Mol. BioSyst. 10:11 (2014), 2954–2964.
12. Ishtikhar, M., Rabbani, G., Khan, R.H., Interaction of 5-fluoro-5′-deoxyuridine with human serum albumin under physiological and non-physiological condition: a biophysical investigation. Colloids Surf. B: Biointerfaces 123 (2014), 469–477.
13. Astolfi, P., Giorgini, E., Gambini, V., Rossi, B., Vaccari, L., Vita, F., et al. Lyotropic liquid-crystalline nanosystems as drug delivery agents for 5-fluorouracil: structure and cytotoxicity. Langmuir 33 (2017), 12369–12378.
14. Kouchakzadeh, H., Hoseini Makarem, S., Shojaosadati, S., Simultaneous loading of 5-florouracil and SPIONs in HSA nanoparticles: optimization of preparation, characterization and in vitro drug release study. Nanomed. J. 3 (2016), 35–42.
15. Kolesar, J.M., Johnson, C.L., Freeberg, B.L., Berlin, J.D., Schiller, J.H., Warfarin—5-FU interaction—a consecutive case series. Pharmacother. J. Hum. Pharmacol. Drug Ther. 19 (1999), 1445–1449.
16. Aydin, R., Pulat, M., 5-Fluorouracil encapsulated chitosan nanoparticles for pH-stimulated drug delivery: evaluation of controlled release kinetics. J. Nanomater., 2012, 2012, 42.
17. Reddy, A.B., Manjula, B., Jayaramudu, T., Sadiku, E., Babu, P.A., Selvam, S.P., 5-Fluorouracil loaded chitosan–PVA/Na+ MMT nanocomposite films for drug release and antimicrobial activity. Nano-Micro Lett., 2016, 1–10.
18. Burke, C.W., Alexander, E., Timbie, K., Kilbanov, A.L., Price, R.J., Ultrasound-activated agents comprised of 5FU-bearing nanoparticles bonded to microbubbles inhibit solid tumor growth and improve survival. Mol. Ther. 22 (2014), 321–328.
19. Han, R., Sun, Y., Kang, C., Sun, H., Wei, W., Amphiphilic dendritic nanomicelle-mediated co-delivery of 5-fluorouracil and doxorubicin for enhanced therapeutic efficacy. J. Drug Target., 2016, 1–28.
20. Moon, J.H., Kim, J.G., Sohn, S.K., Baek, J.H., Cho, Y.Y., Chae, Y.S., et al. Outpatient-basis chemotherapy of oxaliplatin, 5-fluorouracil, and leucovorin as first-line treatment for patients with metastatic or recurrent colorectal cancer. J. Korean Med. Sci. 22 (2007), 400–404.
21. Zhu, P., Zhao, N., Sheng, D., Hou, J., Hao, C., Yang, X., et al. Inhibition of growth and metastasis of colon cancer by delivering 5-fluorouracil-loaded Pluronic P85 copolymer micelles. Sci. Rep., 6, 2016.
22. Yamada, Y., Ohtsu, A., Boku, N., Miyata, Y., Shimada, Y., Doi, T., et al. Phase I/II study of oxaliplatin with weekly bolus fluorouracil and high-dose leucovorin (ROX) as first-line therapy for patients with colorectal cancer. Jpn. J. Clin. Oncol. 36 (2006), 218–223.
23. Divsalar, A., Saboury, A., Yousefi, R., Moosavi-Movahedi, A., Mansoori-Torshizi, H., Spectroscopic and cytotoxic studies of the novel designed palladium (II) complexes: β-lactoglobulin and K562 as the targets. Int. J. Biol. Macromol. 40 (2007), 381–386.
24. Mansouri-Torshizi, H., Shahraki, S., Nezami, Z.S., Ghahghaei, A., Najmedini, S., Divsalar, A., et al. Platinum (II)/palladium (II) complexes with n-propyldithiocarbamate and 2, 2′-bipyridine: synthesis, characterization, biological activity and interaction with calf thymus DNA. Compl. Met. 1 (2014), 23–31.
25. Shahraki, S., Mansouri-Torshizi, H., Sadeghi, M., Divsalar, A., Saboury, A.-A., Novel Pt (II) complex and its Pd (II) aanalogue. Synthesis, characterization, cytotoxicity and DNA-interaction. Biom. J. 1 (2015), 242–253.
26. Brauckmann, C., Wehe, C.A., Kieshauer, M., Lanvers-Kaminsky, C., Sperling, M., Karst, U., The interaction of platinum-based drugs with native biologically relevant proteins. Anal. Bioanal. Chem. 405 (2013), 1855–1864.
27. Raymond, E., Chaney, S., Taamma, A., Cvitkovic, E., Oxaliplatin: a review of preclinical and clinical studies. Ann. Oncol. 9 (1998), 1053–1071.
28. Ghalandari, B., Divsalar, A., Saboury, A.A., Haertlé, T., Parivar, K., Bazl, R., et al. Spectroscopic and theoretical investigation of oxali–palladium interactions with β-lactoglobulin. Spectrochim. Acta A Mol. Biomol. Spectrosc. 118 (2014), 1038–1046.
29. Eslami Moghadam, M., Saidifar, M., Divsalar, A., Mansouri-Torshizi, H., Saboury, A.A., Farhangian, H., et al. Rich spectroscopic and molecular dynamic studies on the interaction of cytotoxic Pt (II) and Pd (II) complexes of glycine derivatives with calf thymus DNA. J. Biomol. Struct. Dyn. 34 (2016), 206–222.
30. Alcindor, T., Beauger, N., Oxaliplatin: a review in the era of molecularly targeted therapy. Curr. Oncol., 18, 2011.
31. Morris, G.M., Huey, R., Lindstrom, W., Sanner, M.F., Belew, R.K., Goodsell, D.S., Olson, A.J., AutoDock 4 and AutoDockTools4: automated docking with selective receptor flexibility. J. Comput. Chem. 30 (2009), 2785–2791.
32. HyperChem8.0.6, Molecular visualization and Simulation Program Package. 1998, Hypercube, Inc., Gainesville.
33. Frisch, M.J., Trucks, G.W., Schlegel, H.B., Scuseria, G.E., Robb, M.A., Cheeseman, J.R., Zakrzewski, V.G., Montgomery, J.A. Jr., Stratmann, R.E., Burant, J.C., Dapprich, S., Millam, J.M., Daniels, A.D., Kudin, K.N., Strain, M.C., Farkas, O., Tomasi, J., Barone, V., Cossi, M., Cammi, R., Mennucci, B., Pomelli, C., Adamo, C., Clifford, S., Ochterski, J., Petersson, G.A., Ayala, P.Y., Cui, Q., Morokuma, K., Malick, D.K., Rabuck, A.D., Raghavachari, K., Foresman, J.B., Cioslowski, J., Ortiz, J.V., Baboul, A.G., Stefanov, B.B., Liu, G., Liashenko, A., Piskorz, P., Komaromi, I., Gomperts, R., Martin, R.L., Fox, D.J., Keith, T., Al-Laham, M.A., Peng, C.Y., Nanayakkara, A., Gonzalez, C., Challacombe, M., Gill, P.M.W., Johnson, B., Chen, W., Wong, M.W., Andres, J.L., Gonzalez, C., Head-Gordon, M., Replogle, E.S., Pople, J.A., Gaussian 98, Revision A.7. 1998, Gaussian, Inc., Pittsburgh, PA.
34. Yang, M.C., Guan, H.H., Liu, M.Y., Lin, Y.H., Yang, J.M., Chen, W.L., Chen, C.J., Mao, S.J., Crystal structure of a secondary vitamin D3 binding site of milk beta-lactoglobulin, proteins. Struct. Funct. Bioinforma. 17 (2008), 1197–1210.
35. Bazl, R., Ganjali, M.R., Saboury, A.A., Foroumadi, A., Nourozi, P., Amanlou, M., A new strategy based on pharmacophore-based virtual screening in adenosine deaminase inhibitors detection and in-vitro study. Daru, 20, 2012, 64.
36. Wolber, G., Dornhofer, A.A., Langer, T., Efficient overlay of small organic molecules using 3D pharmacophores. J. Comput. Aided Mol. Des. 20 (2006), 773–788.
37. Morris, G.M., Goodsell, D.S., Halliday, R.S., Huey, R., Hart, W.E., Belew, R.K., Olson, A.J., Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function. J. Comput. Chem. 19 (1998), 1639–1662.
38. Sanner, M.F., Python: a programming language for software integration and development. J. Mol. Graph Model 17 (1999), 57–61.
39. Humphrey, W., Dalke, A., Schulten, K., VMD- visual molecular dynamics. J. Mol. Graph. 14 (1996), 33–38.
40. Shahraki, S., Heydari, A., Saeidifar, M., Gomroki, M., Biophysical and computational comparison on the binding affinity of three important nutrients to β-lactoglobulin: folic acid, ascorbic acid and vitamin K3. J. Biomol. Struct. Dyn., 2017, 1–29.
41. Divsalar, A., Khodabakhshian, S., Probing the binding site of a new synthesized anti-cancer compound to HSA via competitive ligand binding method. J. Mol. Liq. 206 (2015), 82–88.
42. Abbasi-Tajarag, K., Divsalar, A., Saboury, A., Ghalandari, B., Ghourchian, H., Destructive effect of anticancer oxali-palladium on heme degradation through the generation of endogenous hydrogen peroxide. J. Biomol. Struct. Dyn., 2016, 1–12.
43. Sun, Y., Wei, S., Yin, C., Liu, L., Hu, C., Zhao, Y., et al. Synthesis and spectroscopic characterization of 4-butoxyethoxy-N-octadecyl-1, 8-naphthalimide as a new fluorescent probe for the determination of proteins. Bioorg. Med. Chem. Lett. 21 (2011), 3798–3804.
44. Bakkialakshmi, S., Chandrakala, D., A study on the interaction of 5-fluorouracil with human serum albumin using fluorescence quenching method. J. Pharm. Sci. Res. 3 (2011), 1326–1329.
45. Tabassum, S., Al-Asbahy, W.M., Afzal, M., Arjmand, F., Synthesis, characterization and interaction studies of copper based drug with human serum albumin (HSA): spectroscopic and molecular docking investigations. J. Photochem. Photobiol. B Biol. 114 (2012), 132–139.
46. Kandagal, P., Ashoka, S., Seetharamappa, J., Shaikh, S., Jadegoud, Y., Ijare, O., Study of the interaction of an anticancer drug with human and bovine serum albumin: spectroscopic approach. J. Pharm. Biomed. Anal. 41 (2006), 393–399.
47. Yang, L., Huo, D., Hou, C., Yang, M., Fa, H., Luo, X., Interaction of monosulfonate tetraphenyl porphyrin (H 2 TPPS 1) with plant-esterase: determination of the binding mechanism by spectroscopic methods. Spectrochim. Acta A Mol. Biomol. Spectrosc. 78 (2011), 1349–1355.
48. Hu, Y.-J., Liu, Y., Shen, X.-S., Fang, X.-Y., Qu, S.-S., Studies on the interaction between 1-hexylcarbamoyl-5-fluorouracil and bovine serum albumin. J. Mol. Struct. 738 (2005), 143–147.
49. Han, R., Sun, Y., Kang, C., Sun, H., Wei, W., Amphiphilic dendritic nanomicelle-mediated co-delivery of 5-fluorouracil and doxorubicin for enhanced therapeutic efficacy. J. Drug Target. 25 (2017), 140–148.
50. Saboury, A., Karbassi, F., Thermodynamic studies on the interaction of calcium ions with alpha-amylase. Thermochim. Acta 362 (2000), 121–129.
51. Saboury, A., Moosavi-Movahedi, A., Derivation of the thermodynamic parameters involved in the elucidation of protein thermal profiles. Biochem. Educ. 23 (1995), 164–167.